Anti-IL-6/IFNb2 Antibody (Sirukumab)
Catalog No.
F1293
Anti-IL-6/IFNb2 Antibody (Sirukumab)
Featured Products
Sirukumab (CNTO-136) is a humanized monoclonal anti-IL6 (Interleukin Related) IgG1κ antibody. Sirukumab binds to IL6, preventing IL6-mediated signal transduction and activation of transcriptional activators, thereby blocking the downstream biological effects of IL6. Sirukumab can be used in the study of active lupus nephritis and rheumatoid arthritis.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.58 kDa
Dry ice
1194585-53-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Plivensia, CNTO-136
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P05231
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human IL-6 His at 2 ug/mL can bind Anti-IL-6/IFNb2 Antibody (Sirukumab)
IL-6 / IFNb2
Please avoid freeze-thaw cycles.